Volume 27, Issue 134, April 2023

Systemic amyloidosis misdiagnosed for Crohn's disease: A case report

Salah Ahmd Elshafie¹, Khalid Alnemer², Mohammed A Omair³, Tahany Faisal Alshammari⁴, Tamam Zamil Alshammari⁵, Hussain Abdullah Aljuwayd⁴, Shayma Abduwasea Asrar⁴, Fadi Alakeel⁵, Hussain Gadelkarim Ahmed⁶

¹Department of Gastroentology, Dr. Sulaiman Alhabib Medical group, Arryan, Riyadh, Saudi Arabia
²Department of Cardiology, College of medicine Imam mohammad Ibn Saud Islamic university (IMSIU), Riyadh, Saudi Arabia
³Department of Rheumatology, King Saud University, Riyadh, Saudi Arabia
⁴Department of Medicine Dr. Sulaiman Alhabib Medical group, Arryan, Riyadh, Saudi Arabia
⁵Department of Pathology, King Saud University, Riyadh, Saudi Arabia
⁶Department of Histopathology and Cytology, FMLS, University of Khartoum, Sudan

ABSTRACT

Background: Systemic amyloidosis is characterized by the steady buildup of highly structured fibrils made of autologous proteins in the organs that are affected. Our patient was often told she had Crohn's disease because she had stomach pain, diarrhea, weight loss, anemia and tiredness, but the treatment didn't work. As a result, numerous investigations and laboratory tests were performed, including gastroscopy and colonoscopy. Conclusions: Systemic intestinal amyloidosis can be misdiagnosed for Crohn's disease. When a similar clinical circumstance occurs, we hope that our report will remind our colleagues to be on the lookout for underlying disorders so that a quick diagnosis and successful treatment can be provided.

Keywords: Amyloidosis, Crohn's disease, abdominal pain, gastrointestinal

Medical Science, 2023, 27, e193ms2986

PDF

DOI: https://doi.org/10.54905/disssi/v27i134/e193ms2986

Published: 15 April 2023